Narwhal Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $347K | Sell |
959
-58
| -6% | -$19.9K | 0.02% | 140 |
|
|
2026
Q1 | $358K | Sell |
1,017
-97
| -9% | -$34.6K | 0.03% | 140 |
|
|
2025
Q4 | $365K | Sell |
1,114
-23
| -2% | -$7.3K | 0.03% | 135 |
|
|
2025
Q3 | $321K | Sell |
1,137
-33
| -3% | -$9.57K | 0.02% | 141 |
|
|
2025
Q2 | $327K | Sell |
1,170
-3,886
| -77% | -$1.1M | 0.03% | 142 |
|
|
2025
Q1 | $1.58M | Sell |
5,056
-26
| -0.5% | -$7.68K | 0.14% | 90 |
|
|
2024
Q4 | $1.32M | Sell |
5,082
-45
| -0.9% | -$13.4K | 0.12% | 92 |
|
|
2024
Q3 | $1.65M | Sell |
5,127
-20
| -0.4% | -$6.54K | 0.15% | 85 |
|
|
2024
Q2 | $1.61M | Sell |
5,147
-47
| -0.9% | -$13.8K | 0.15% | 85 |
|
|
2024
Q1 | $1.48M | Hold |
5,194
| – | – | 0.14% | 89 |
|
|
2023
Q4 | $1.5M | Sell |
5,194
-257
| -5% | -$70K | 0.16% | 88 |
|
|
2023
Q3 | $1.47M | Sell |
5,451
-333
| -6% | -$83.1K | 0.18% | 89 |
|
|
2023
Q2 | $1.28M | Sell |
5,784
-92
| -2% | -$21.3K | 0.15% | 93 |
|
|
2023
Q1 | $1.42M | Sell |
5,876
-13
| -0.2% | -$3.19K | 0.18% | 91 |
|
|
2022
Q4 | $1.55M | Buy |
5,889
+63
| +1% | +$16.9K | 0.21% | 87 |
|
|
2022
Q3 | $1.31M | Buy |
5,826
+190
| +3% | +$46.1K | 0.19% | 87 |
|
|
2022
Q2 | $1.37M | Buy |
5,636
+839
| +17% | +$206K | 0.19% | 83 |
|
|
2022
Q1 | $1.16M | Sell |
4,797
-856
| -15% | -$197K | 0.14% | 88 |
|
|
2021
Q4 | $1.27M | Sell |
5,653
-265
| -4% | -$55.9K | 0.14% | 86 |
|
|
2021
Q3 | $1.26M | Sell |
5,918
-1,984
| -25% | -$457K | 0.16% | 84 |
|
|
2021
Q2 | $1.93M | Sell |
7,902
-1,541
| -16% | -$379K | 0.24% | 74 |
|
|
2021
Q1 | $2.35M | Sell |
9,443
-1,085
| -10% | -$259K | 0.32% | 68 |
|
|
2020
Q4 | $2.42M | Buy |
10,528
+1,580
| +18% | +$364K | 0.34% | 63 |
|
|
2020
Q3 | $2.27M | Buy |
8,948
+860
| +11% | +$213K | 0.37% | 63 |
|
|
2020
Q2 | $1.91M | Buy |
8,088
+16
| +0.2% | +$3.65K | 0.33% | 65 |
|
|
2020
Q1 | $1.64M | Buy |
8,072
+2,078
| +35% | +$454K | 0.35% | 64 |
|
|
2019
Q4 | $1.45M | Buy |
5,994
+56
| +0.9% | +$12.3K | 0.27% | 76 |
|
|
2019
Q3 | $1.15M | Buy |
5,938
+1,249
| +27% | +$240K | 0.23% | 83 |
|
|
2019
Q2 | $864K | Buy |
4,689
+698
| +17% | +$125K | 0.18% | 90 |
|
|
2019
Q1 | $758K | Hold |
3,991
| – | – | 0.16% | 97 |
|
|
2018
Q4 | $777K | Hold |
3,991
| – | – | 0.19% | 96 |
|
|
2018
Q3 | $827K | Buy |
3,991
+41
| +1% | +$8.08K | 0.18% | 101 |
|
|
2018
Q2 | $729K | Sell |
3,950
-3,860
| -49% | -$683K | 0.17% | 105 |
|
|
2018
Q1 | $1.33M | Sell |
7,810
-10,950
| -58% | -$2.01M | 0.31% | 91 |
|
|
2017
Q4 | $3.26M | Buy |
18,760
+250
| +1% | +$44.2K | 0.75% | 46 |
|
|
2017
Q3 | $3.45M | Sell |
18,510
-1,400
| -7% | -$248K | 0.86% | 40 |
|
|
2017
Q2 | $3.43M | Buy |
19,910
+50
| +0.3% | +$8.13K | 0.89% | 41 |
|
|
2017
Q1 | $3.26M | Buy |
19,860
+1,625
| +9% | +$270K | 0.91% | 34 |
|
|
2016
Q4 | $2.67M | Buy |
18,235
+5,640
| +45% | +$849K | 0.8% | 41 |
|
|
2016
Q3 | $2.1M | Hold |
12,595
| – | – | 0.66% | 52 |
|
|
2016
Q2 | $1.92M | Buy |
12,595
+2,350
| +23% | +$365K | 0.6% | 57 |
|
|
2016
Q1 | $1.54M | Buy |
10,245
+250
| +3% | +$37.1K | 0.5% | 68 |
|
|
2015
Q4 | $1.62M | Hold |
9,995
| – | – | 0.56% | 62 |
|
|
2015
Q3 | $1.38M | Hold |
9,995
| – | – | 0.52% | 63 |
|
|
2015
Q2 | $1.53M | Hold |
9,995
| – | – | 0.56% | 61 |
|
|
2015
Q1 | $1.6M | Hold |
9,995
| – | – | 0.58% | 60 |
|
|
2014
Q4 | $1.59M | Sell |
9,995
-130
| -1% | -$20.3K | 0.62% | 62 |
|
|
2014
Q3 | $1.42M | Hold |
10,125
| – | – | 0.57% | 65 |
|
|
2014
Q2 | $1.2M | Sell |
10,125
-140
| -1% | -$16.2K | 0.46% | 76 |
|
|
2014
Q1 | $1.27M | Hold |
10,265
| – | – | 0.53% | 74 |
|
|
2013
Q4 | $1.17M | Sell |
10,265
-1,375
| -12% | -$156K | 0.48% | 80 |
|
|
2013
Q3 | $1.3M | Hold |
11,640
| – | – | 0.62% | 64 |
|
|
2013
Q2 | $1.15M | Buy |
+11,640
| New | +$1.21M | 0.55% | 71 |
|
Other funds holding AMGN
Narwhal Capital Management's AMGN Position: Q2 2026 in Review
Narwhal Capital Management reduced its Amgen (AMGN) stake by 5.7% in Q2 2026, selling an estimated $19.9K and leaving 959 shares worth $347K. The position accounts for 0.02% of the portfolio, ranked #140.
Narwhal Capital Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.45M in Q3 2017. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Narwhal Capital Management held 959 shares of Amgen worth $347K as of Q2 2026.
- Narwhal Capital Management sold 58 Amgen shares in Q2 2026, an estimated $19.9K.
- Amgen made up 0.02% of Narwhal Capital Management's portfolio in Q2 2026, its #140 holding.
- Narwhal Capital Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- Narwhal Capital Management's Amgen position peaked at $3.45M in Q3 2017.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Narwhal Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.